
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances and gaps in SARS-CoV-2 infection models
César Muñoz‐Fontela, Lina Widerspick, Randy A. Albrecht, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 1, pp. e1010161-e1010161
Open Access | Times Cited: 77
César Muñoz‐Fontela, Lina Widerspick, Randy A. Albrecht, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 1, pp. e1010161-e1010161
Open Access | Times Cited: 77
Showing 1-25 of 77 citing articles:
The evolution of SARS-CoV-2
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 703
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 703
The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
Lisa Bauer, Brigitta M. Laksono, Femke M.S. de Vrij, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 5, pp. 358-368
Open Access | Times Cited: 183
Lisa Bauer, Brigitta M. Laksono, Femke M.S. de Vrij, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 5, pp. 358-368
Open Access | Times Cited: 183
Accelerating antiviral drug discovery: lessons from COVID-19
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 90
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 90
Animal models for COVID-19: advances, gaps and perspectives
Changfa Fan, Yong Wu, Rui Xiong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 79
Changfa Fan, Yong Wu, Rui Xiong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 79
An early warning system for emerging SARS-CoV-2 variants
Lorenzo Subissi, Anne von Gottberg, Lipi Thukral, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1110-1115
Open Access | Times Cited: 69
Lorenzo Subissi, Anne von Gottberg, Lipi Thukral, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1110-1115
Open Access | Times Cited: 69
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection
Christina M. Arieta, Yushu Joy Xie, Daniel Rothenberg, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2392-2409.e21
Open Access | Times Cited: 57
Christina M. Arieta, Yushu Joy Xie, Daniel Rothenberg, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2392-2409.e21
Open Access | Times Cited: 57
CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection
Jian Zheng, Hima Dhakal, Enya Qing, et al.
Journal of Clinical Investigation (2025)
Open Access | Times Cited: 1
Jian Zheng, Hima Dhakal, Enya Qing, et al.
Journal of Clinical Investigation (2025)
Open Access | Times Cited: 1
Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses
Cillian Gartlan, Tom Tipton, Francisco J. Salguero, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Cillian Gartlan, Tom Tipton, Francisco J. Salguero, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Antibody-dependent enhancement of toxicity of myotoxin II from Bothrops asper
Christoffer V. Sørensen, Julián Fernández, Anna Christina Adams, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Christoffer V. Sørensen, Julián Fernández, Anna Christina Adams, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Cryo-EM structures and binding of mouse and human ACE2 to SARS-CoV-2 variants of concern indicate that mutations enabling immune escape could expand host range
Dongchun Ni, Priscilla Turelli, Bertrand Beckert, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1011206-e1011206
Open Access | Times Cited: 20
Dongchun Ni, Priscilla Turelli, Bertrand Beckert, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1011206-e1011206
Open Access | Times Cited: 20
A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy
Penny L. Moore, T. Leighton, Julie Ostrowsky, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2101-2112
Open Access | Times Cited: 19
Penny L. Moore, T. Leighton, Julie Ostrowsky, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2101-2112
Open Access | Times Cited: 19
The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps
Anabelle Wong, Laura Andrea Barrero Guevara, Elizabeth Goult, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 3, pp. e1011167-e1011167
Open Access | Times Cited: 19
Anabelle Wong, Laura Andrea Barrero Guevara, Elizabeth Goult, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 3, pp. e1011167-e1011167
Open Access | Times Cited: 19
Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice
Côme Thieulent, Wellesley Dittmar, Udeni B. R. Balasuriya, et al.
mSphere (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 15
Côme Thieulent, Wellesley Dittmar, Udeni B. R. Balasuriya, et al.
mSphere (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 15
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control
Shen Wang, Wujian Li, Zhenshan Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Shen Wang, Wujian Li, Zhenshan Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine
Kayvon Modjarrad, Ye Che, Wei Chen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Kayvon Modjarrad, Ye Che, Wei Chen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques
Christopher T Edwards, Kirti A. Karunakaran, Elijah Garcia, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012456-e1012456
Open Access
Christopher T Edwards, Kirti A. Karunakaran, Elijah Garcia, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012456-e1012456
Open Access
Animal Models for Long COVID: Current Advances, Limitations, and Future Directions
Yu Zhang, Huan Chen, Yumeng Li, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access
Yu Zhang, Huan Chen, Yumeng Li, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access
Recent Advances in Nose and Lung Organoid Models for Respiratory Viral Research
Lennart Svensson, Johan Nordgren, Åke Lundkvist, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 349-349
Open Access
Lennart Svensson, Johan Nordgren, Åke Lundkvist, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 349-349
Open Access
Organoids and Organ-On-Chip Models for COVID-19 Research and its Application in Modernization of Traditional Chinese Medicine: Opportunities and Challenges
Hongda Sheng, Yanchun Liang, Volker M. Lauschke, et al.
Engineering (2025)
Open Access
Hongda Sheng, Yanchun Liang, Volker M. Lauschke, et al.
Engineering (2025)
Open Access
Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern
Patrick O. Azevedo, Natália Satchiko Hojo-Souza, Lídia Faustino, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 12
Patrick O. Azevedo, Natália Satchiko Hojo-Souza, Lídia Faustino, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 12
Host Genetic Variation Impacts SARS-CoV-2 Vaccination Response in the Diversity Outbred Mouse Population
Marta C Cruz Cisneros, Elizabeth J. Anderson, Brea K. Hampton, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 103-103
Open Access | Times Cited: 4
Marta C Cruz Cisneros, Elizabeth J. Anderson, Brea K. Hampton, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 103-103
Open Access | Times Cited: 4
Immune Responses to SARS-CoV-2 in Pregnancy: Implications for the Health of the Next Generation
Lydia L. Shook, Lindsay T. Fourman, Andrea G. Edlow
The Journal of Immunology (2022) Vol. 209, Iss. 8, pp. 1465-1473
Open Access | Times Cited: 20
Lydia L. Shook, Lindsay T. Fourman, Andrea G. Edlow
The Journal of Immunology (2022) Vol. 209, Iss. 8, pp. 1465-1473
Open Access | Times Cited: 20
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
William HK Schilling, Podjanee Jittamala, James A Watson, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 11
William HK Schilling, Podjanee Jittamala, James A Watson, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 11
Pathogenicity, tissue tropism and potential vertical transmission of SARSr-CoV-2 in Malayan pangolins
Xianghui Liang, Xiaohong Chen, Junqiong Zhai, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 5, pp. e1011384-e1011384
Open Access | Times Cited: 11
Xianghui Liang, Xiaohong Chen, Junqiong Zhai, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 5, pp. e1011384-e1011384
Open Access | Times Cited: 11
A highly susceptible hACE2-transgenic mouse model for SARS-CoV-2 research
Gang Liu, Min Zhang, Baolei Wu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 3
Gang Liu, Min Zhang, Baolei Wu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 3